Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 263-218-7 | CAS number: 61792-31-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 05 - 19 Jun 2020
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
- Report date:
- 2020
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method)
- Version / remarks:
- adopted in 2018
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- activation of keratinocytes
Test material
- Reference substance name:
- N-[3-(dimethylamino)propyl]dodecanamide N-oxide
- EC Number:
- 263-218-7
- EC Name:
- N-[3-(dimethylamino)propyl]dodecanamide N-oxide
- Cas Number:
- 61792-31-2
- Molecular formula:
- C17H36N2O2
- IUPAC Name:
- N-[3-(dimethylamino)propyl]dodecanamide N-oxide
Constituent 1
In vitro test system
- Details on the study design:
- TEST CELL LINE: KeratinoSensTM
- Cell type: HaCaT cells (human keratinocytes)
- Source: Givaudan (Duebendorf, Switzerland)
- Passage number: 11 (Experiment I) and 14 (Experiment II)
TEST METHOD
The in vitro KeratinoSensTM assay enables the detection of the skin sensitizing potential of a test item by analysing the activation of keratinocytes. This activation step represents the second molecular key event of the adverse outcome pathway, which is the induction of cyto-protective signaling pathways in keratinocytes in response to electrophiles and oxidative stress. The KeratinoSens assay addresses the effect on the antioxidant response element (ARE) Nrf2-dependent pathway in the transgenic KeratinoSens cell line, which stably expresses the ARE-Nrf2-dependet luciferase gene. The Nrf2-dependent induction of this reporter gene is analysed upon exposure to test chemicals. Luminescence detection in the cell lysate after 48 ± 1 h of exposure at 37 ± 1.0 °C indicates luciferase induction and allows the discrimination between skin sensitisers and non-sensitisers.
TEST SUBSTANCE PREPARATION
A correction factor of 3.4 was used according to the purity/composition. Based on the results of a solubility test, the test item was dissolved in DMSO at 200 mM. In a 2-fold dilution series, 12 concentrations were prepared for application in cell culture medium. The final DMSO concentration in the cell culture medium was 1%.
CONCENTRATIONS:
0.98, 2.0, 3.9, 7.8, 16, 31, 63, 125, 250, 500, 1000 and 2000 µg/mL
CONTROLS:
VEHICLE CONTROL: Dimethyl sulfoxide (DMSO, Merck, Darmstadt, Germany)
Final concentration in the exposure medium: 1% (v/v)
POSITIVE CONTROL: Ethylene dimethacrylate glycol (EDMG, Sigma, Zwijndrecht, the Netherlands)
Solvent: DMSO, 1% (v/v) final concentration in the exposure medium
Concentration range: 7.8 – 250 µM
CELL CULTURE:
MEDIA:
Basic medium: Dulbecco’s minimal (DMEM glutamax) supplemented with 9.1% (v/v) heat-inactivated (56°C; 30 min) fetal calf serum (Life Technologies, Bleiswijk, the Netherlands).
Maintenance medium: Dulbecco’s minimal (DMEM glutamax) supplemented with 9.1% (v/v) heat-inactivated (56°C; 30 min) fetal calf serum and geneticin (500 µg/mL).
Exposure medium: Dulbecco’s minimal (DMEM glutamax) supplemented with 1% (v/v) heat-inactivated (56°C; 30 min) fetal calf serum.
ENVIRONMENTAL CONDITIONS:
- Temperature (°C): 37 ± 1.0 (actual range: 36.0 – 37.2)
- CO2 (%): 5 ± 0.5
- Humidity (%): 80 – 100 (actual range: 29 – 93)
MAINTAINANCE:
Cells were sub-cultured upon reaching 80-90% confluency. To maintain the integrity of the response, the cells were grown for more than one passage from the frozen stock, and were not cultured for more than 25 passages from the frozen stock.
NUMBER OF REPLICATIONS: triplicates in two independent experiments
EXPERIMENTAL PROCEDURE:
Cells were seeded 10,000 cells / well in a 96-well format in basic medium. One plate was used for the luciferase activity measurements, and one parallel replicate was used for the MTT cell viability assay. After overnight cultivation, the medium was removed, replaced with antibiotic-free exposure medium and the test and control items were applied. The cells were exposed for 48 ± 1 h at 37 ± 1.0 °C. After the exposure period, luciferase activity was evaluated by luminescence measurement and cytotoxicity was assessed using the MTT viability assay.
LUCIFERASE ASSAY:
- Assay: Steady-Glo Luciferase Assay (Promega, Leiden, the Netherlands)
- Incubation time: 5 min at room temperature
- Luminometer: TECAN Infinite® M200 Pro Plate Reader
MTT VIABILITY ASSAY:
- MTT concentration: 5 mg/mL (11%)
- Incubation time: 3 – 4 h at 37 ± 1 °C
- Spectrophotometer: TECAN Infinite® M200 Pro Plate Reader
- Wavelength: 570 nm
EXPOSURE: 48 ± 1 h at 37 ± 1.0 °C
Results and discussion
- Positive control results:
- Ethylene dimethacrylate glycol (EDMG) was tested as positive control in a concentration range of 7.8 - 250 µM. In both experiments, luciferase activity increased dose-dependently with statistical significance. The induction at 250 µM was higher than 2-fold (2.51-fold and 2.79-fold in experiment 1 and 2, respectively). The EC1.5 was well within two standard deviations of the historical mean (61 µM in the first and 49 µM in the second experiment). Thus all acceptability criteria were met.
In vitro / in chemico
Resultsopen allclose all
- Key result
- Run / experiment:
- other: 48 h exposure / Experiment 1
- Parameter:
- other: Imax
- Value:
- 1.31
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- Cytotoxicity was observed. The calculated IC30 was 159 µM and the calculated IC50 was 185 µM.
- Key result
- Run / experiment:
- other: 48 h exposure / Experiment 1
- Parameter:
- other: EC1.5
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- Cytotoxicity was observed. The calculated IC30 was 159 µM and the calculated IC50 was 185 µM.
- Key result
- Run / experiment:
- other: 48 h exposure / Experiment 2
- Parameter:
- other: Imax
- Value:
- 1.31
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- Cytotoxicity was observed. The calculated IC30 was 108 µM and the calculated IC50 was 156 µM.
- Key result
- Run / experiment:
- other: 48 h exposure / Experiment 2
- Parameter:
- other: EC1.5
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- Cytotoxicity was observed. The calculated IC30 was 108 µM and the calculated IC50 was 156 µM.
- Other effects / acceptance of results:
- DEMONSTRATION OF TECHNICAL PROFICIENCY:
Technical proficiency of the test system was demonstrated with 10 substances according to OECD 442D.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for positive control: Yes, the luciferase activity induction obtained with the positive control was statistically significant above the threshold of 1.5-fold in at least one concentration. In addition, the EC1.5 of the positive control was within two standard deviations of the historical mean (61 µM and 49 µM in experiment 1 and 2, respectively). A dose response was observed and the induction at 250 µM was higher than 2-fold (2.51-fold and 2.79-fold in experiment 1 and 2, respectively).
- Acceptance criteria met for variability between replicate measurements: Yes, the average coefficient of variation of the luminescence reading for the vehicle control DMSO was below 20% (5.1% and 4.2% in experiment 1 and 2, respectively).
For details on historical control data of the positive control please refer to Table 4 under "Any other information in results incl. tables".
Any other information on results incl. tables
Table 1: Results of the KeratinoSens assay
|
EC1.5 (µM) |
Imax |
IC30 (µM) |
IC50 (µM) |
Test item Experiment 1 |
NA |
1.31 |
159 |
185 |
Test item Experiment 2 |
NA |
1.31 |
108 |
156 |
Pos Control Experiment 1 |
61 |
2.51 |
NA |
NA |
Pos Control Experiment 2 |
49 |
2.79 |
NA |
NA |
Table 2: Luminescence and viability values of the first experiment
Concentration (µM) | Test item | Positive control | ||
Luminescence | Viability (%) | Luminescence | Viability (%) | |
0.98 | 0.93 | 113.4 | - | - |
2 | 0.97 | 100.8 | - | - |
3.9 | 1.06 | 90.3 | - | - |
7.8 | 1.03 | 95.6 | 0.92 | 120 |
16 | 1.06 | 88 | 1.03 | 95.5 |
31 | 1 | 95 | 1.22 | 108.1 |
63 | 0.91 | 91.2 | 1.51*** | 111.1 |
125 | 1.31 | 96 | 1.85*** | 114.6 |
250 | 0 | -0.3 | 2.51*** | 111 |
500 | 0 | -0.2 | - | - |
1000 | 0 | -0.2 | - | - |
2000 | 0 | -0.2 | - | - |
***p<0.001 Student’s t test
Table 3: Luminescence and viability values of the second experiment
Concentration (µM) | Test item | Positive control | ||
Luminescence | Viability (%) | Luminescence | Viability (%) | |
0.98 | 1 | 108.7 | - | - |
2 | 0.99 | 98.6 | - | - |
3.9 | 0.97 | 84.9 | - | - |
7.8 | 0.98 | 79 | 1.06 | 106.8 |
16 | 1 | 81.3 | 1.09 | 95.4 |
31 | 0.96 | 74.2 | 1.31 | 91.3 |
63 | 0.98 | 78.5 | 1.63*** | 89 |
125 | 1.31 | 66.7 | 1.96*** | 83.6 |
250 | 0 | -0.3 | 2.79*** | 80.3 |
500 | -0.01 | 0.4 | - | - |
1000 | -0.01 | -0.2 | - | - |
2000 | -0.01 | -0.2 | - | - |
***p<0.001 Student’s t test
Table 4: Historical control data for the positive control generated in the testing laboratory in June 2017 - June 2020
Positive control |
||
EC1.5 (µM) |
Imax |
|
95% control Range |
-3.8 – 123 |
-6.86 – 13.51 |
Mean |
59.5 |
3.32 |
SD |
31.6 |
5.09 |
n |
500 |
500 |
SD = standard deviation; n = number of observations
Applicant's summary and conclusion
- Interpretation of results:
- other: no skin sensitising potential based on the key event “keratinocyte activation / inflammatory response”
- Conclusions:
- There is regulatory acceptance in the EU for the application of the KeratinoSens assay to address key event 2: activation of keratinocytes / inflammatory response in the skin sensitisation Adverse Outcome Pathway. Under the conditions of the test, the test substance was negative for keratinocyte activation in two independent experiments. The data generated with this method may not be sufficient to conclude on the absence of skin sensitisation potential of chemicals and should be considered in the context of an integrated approach such as integrated approaches to testing and assessment (IATA).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.